Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

BACKGROUND: Circulating tumour DNA (ctDNA) may serve as a measure of tumour burden and a useful tool for non-invasive monitoring of cancer. However, ctDNA is not always detectable in patients at time of diagnosis of metastatic disease. Therefore, there is a need to understand the correlation between...

詳細記述

保存先:
書誌詳細
出版年:BMC Cancer
主要な著者: McEvoy, Ashleigh C., Warburton, Lydia, Al-Ogaili, Zeyad, Celliers, Liesl, Calapre, Leslie, Pereira, Michelle R., Khattak, Muhammad A., Meniawy, Tarek M., Millward, Michael, Ziman, Melanie, Gray, Elin S.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6038195/
https://ncbi.nlm.nih.gov/pubmed/29986670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4637-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料